Tiaki Therapeutics Company
Tiaki Therapeutics is committed to developing microglia-targeted therapeutics for the treatment of dementias.
Technology:
NeuroTech
Industry:
Regenerative medicine
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2017
Employees Number:
1-10
Funding Status:
Seed
Estimated Revenue:
Less than $1M
Last Funding Type:
Seed
Register and Claim Ownership